Clinical Trial Update: Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and tolerability of OPC-34712 as adjunctive therapy for adults with Major Depressive Disorder has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• OPC-34712

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2015-11-06